JP Morgan Chase’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $561M | Sell |
23,010,244
-4,883,798
| -18% | -$128M | 0.03% | 413 |
|
|
2026
Q1 | $775M | Buy |
27,894,042
+4,552,595
| +20% | +$121M | 0.05% | 312 |
|
|
2025
Q4 | $581M | Sell |
23,341,447
-4,921,895
| -17% | -$124M | 0.04% | 368 |
|
|
2025
Q3 | $720M | Sell |
28,263,342
-1,095,229
| -4% | -$27M | 0.04% | 347 |
|
|
2025
Q2 | $712M | Sell |
29,358,571
-2,906,087
| -9% | -$67.8M | 0.05% | 344 |
|
|
2025
Q1 | $818M | Buy |
32,264,658
+5,144,007
| +19% | +$135M | 0.06% | 279 |
|
|
2024
Q4 | $720M | Sell |
27,120,651
-10,508,722
| -28% | -$285M | 0.05% | 305 |
|
|
2024
Q3 | $1.09B | Sell |
37,629,373
-1,035,674
| -3% | -$30.2M | 0.08% | 225 |
|
|
2024
Q2 | $1.08B | Sell |
38,665,047
-3,055,296
| -7% | -$84.1M | 0.09% | 218 |
|
|
2024
Q1 | $1.16B | Sell |
41,720,343
-1,675,013
| -4% | -$46.5M | 0.1% | 206 |
|
|
2023
Q4 | $1.25B | Buy |
43,395,356
+1,931,073
| +5% | +$58.4M | 0.12% | 174 |
|
|
2023
Q3 | $1.38B | Sell |
41,464,283
-1,512,254
| -4% | -$53.5M | 0.15% | 139 |
|
|
2023
Q2 | $1.58B | Buy |
42,976,537
+7,246,745
| +20% | +$282M | 0.17% | 131 |
|
|
2023
Q1 | $1.46B | Sell |
35,729,792
-13,380,482
| -27% | -$578M | 0.18% | 130 |
|
|
2022
Q4 | $2.52B | Buy |
49,110,274
+9,631,188
| +24% | +$462M | 0.33% | 71 |
|
|
2022
Q3 | $1.73B | Sell |
39,479,086
-1,552,889
| -4% | -$75.5M | 0.25% | 96 |
|
|
2022
Q2 | $2.15B | Buy |
41,031,975
+7,981,650
| +24% | +$407M | 0.3% | 78 |
|
|
2022
Q1 | $1.71B | Buy |
33,050,325
+2,890,178
| +10% | +$150M | 0.21% | 115 |
|
|
2021
Q4 | $1.78B | Buy |
30,160,147
+6,344,714
| +27% | +$314M | 0.21% | 112 |
|
|
2021
Q3 | $1.02B | Sell |
23,815,433
-7,818,268
| -25% | -$346M | 0.13% | 179 |
|
|
2021
Q2 | $1.24B | Sell |
31,633,701
-3,671,391
| -10% | -$143M | 0.15% | 159 |
|
|
2021
Q1 | $1.28B | Buy |
35,305,092
+206,251
| +0.6% | +$7.32M | 0.17% | 143 |
|
|
2020
Q4 | $1.29B | Sell |
35,098,841
-3,025,993
| -8% | -$111M | 0.19% | 127 |
|
|
2020
Q3 | $1.31B | Sell |
38,124,834
-4,327,424
| -10% | -$152M | 0.22% | 97 |
|
|
2020
Q2 | $1.32B | Sell |
42,452,258
-14,859,667
| -26% | -$505M | 0.25% | 87 |
|
|
2020
Q1 | $1.77B | Buy |
57,311,925
+2,786,409
| +5% | +$94.9M | 0.42% | 50 |
|
|
2019
Q4 | $2.03B | Sell |
54,525,516
-40,231,330
| -42% | -$1.43B | 0.38% | 49 |
|
|
2019
Q3 | $3.23B | Sell |
94,756,846
-20,909,776
| -18% | -$760M | 0.64% | 22 |
|
|
2019
Q2 | $4.77B | Buy |
115,666,622
+5,620,476
| +5% | +$223M | 0.93% | 7 |
|
|
2019
Q1 | $4.43B | Sell |
110,046,146
-5,291,623
| -5% | -$212M | 0.91% | 7 |
|
|
2018
Q4 | $4.78B | Sell |
115,337,769
-2,447,777
| -2% | -$102M | 1.1% | 6 |
|
|
2018
Q3 | $4.92B | Buy |
117,785,546
+2,710,198
| +2% | +$104M | 0.94% | 8 |
|
|
2018
Q2 | $3.96B | Buy |
115,075,348
+7,565,251
| +7% | +$259M | 0.81% | 11 |
|
|
2018
Q1 | $3.62B | Sell |
107,510,097
-14,313,149
| -12% | -$492M | 0.78% | 10 |
|
|
2017
Q4 | $4.19B | Buy |
121,823,246
+1,547,264
| +1% | +$52.8M | 0.88% | 10 |
|
|
2017
Q3 | $4.06B | Buy |
120,275,982
+3,641,342
| +3% | +$117M | 0.9% | 8 |
|
|
2017
Q2 | $3.72B | Buy |
116,634,640
+1,042,709
| +0.9% | +$32.9M | 0.85% | 10 |
|
|
2017
Q1 | $3.75B | Sell |
115,591,931
-2,451,793
| -2% | -$77.3M | 0.86% | 11 |
|
|
2016
Q4 | $3.64B | Sell |
118,043,724
-2,879,958
| -2% | -$87.9M | 0.87% | 9 |
|
|
2016
Q3 | $3.89B | Buy |
120,923,682
+5,463,564
| +5% | +$183M | 0.96% | 8 |
|
|
2016
Q2 | $3.86B | Sell |
115,460,118
-7,796,215
| -6% | -$249M | 0.96% | 6 |
|
|
2016
Q1 | $3.47B | Sell |
123,256,333
-1,965,959
| -2% | -$56.2M | 0.89% | 8 |
|
|
2015
Q4 | $3.84B | Buy |
125,222,292
+7,928,216
| +7% | +$249M | 0.96% | 9 |
|
|
2015
Q3 | $3.5B | Buy |
117,294,076
+11,450,836
| +11% | +$367M | 0.93% | 9 |
|
|
2015
Q2 | $3.37B | Buy |
105,843,240
+15,648,935
| +17% | +$510M | 0.79% | 10 |
|
|
2015
Q1 | $2.98B | Buy |
90,194,305
+28,920,739
| +47% | +$919M | 0.68% | 16 |
|
|
2014
Q4 | $1.81B | Buy |
61,273,566
+2,828,898
| +5% | +$81.1M | 0.41% | 39 |
|
|
2014
Q3 | $1.64B | Buy |
58,444,668
+456,986
| +0.8% | +$12.8M | 0.39% | 45 |
|
|
2014
Q2 | $1.63B | Sell |
57,987,682
-502,352
| -0.9% | -$14.3M | 0.41% | 42 |
|
|
2014
Q1 | $1.78B | Sell |
58,490,034
-2,079,651
| -3% | -$62M | 0.49% | 32 |
|
|
2013
Q4 | $1.76B | Sell |
60,569,685
-2,736,679
| -4% | -$79.6M | 0.5% | 33 |
|
|
2013
Q3 | $1.73B | Sell |
63,306,364
-3,370,880
| -5% | -$91.7M | 0.51% | 27 |
|
|
2013
Q2 | $1.77B | Buy |
+66,677,244
| New | +$1.84B | 0.56% | 25 |
|
Other funds holding PFE
JP Morgan Chase's PFE Position: Q2 2026 in Review
JP Morgan Chase reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $128M and leaving 23,010,244 shares worth $561M. The position accounts for 0.03% of the portfolio, ranked #413.
JP Morgan Chase first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.92B in Q3 2018. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- JP Morgan Chase held 23,010,244 shares of Pfizer worth $561M as of Q2 2026.
- JP Morgan Chase sold 4,883,798 Pfizer shares in Q2 2026, an estimated $128M.
- Pfizer made up 0.03% of JP Morgan Chase's portfolio in Q2 2026, its #413 holding.
- JP Morgan Chase first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Pfizer position peaked at $4.92B in Q3 2018.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.